MedPath

Hallux Mobilization in Patients With Parkinson's Disease

Completed
Conditions
Parkinson Disease
Interventions
Other: MIRT
Other: Mobilization of the metatarsophalangeal joint of the hallux
Registration Number
NCT02098642
Lead Sponsor
Ospedale Generale Di Zona Moriggia-Pelascini
Brief Summary

Parkinson's disease is a degenerative disorder of the central nervous system. The motor symptoms of Parkinson's disease result from the death of dopamine-generating cells in the substantia nigra, a region of the midbrain; the cause of this cell death is unknown. Early in the course of the disease, the most obvious symptoms are movement-related; these include shaking, rigidity, slowness of movement and difficulty with walking and gait. A multidisciplinary intensive rehabilitation treatment (MIRT) is able to improve different parameters in PD that are poorly responsive to dopaminergic therapy. In this study, we aim to understand whether the passive mobilization of the metatarsophalangeal joint of the hallux determines an increase in the joint range in this district, allowing to improve, at least, the gait.

Detailed Description

Parkinson's disease is a degenerative disorder of the central nervous system. The motor symptoms of Parkinson's disease result from the death of dopamine-generating cells in the substantia nigra, a region of the midbrain; the cause of this cell death is unknown. Early in the course of the disease, the most obvious symptoms are movement-related; these include shaking, rigidity, slowness of movement and difficulty with walking and gait. The main families of drugs useful for treating motor symptoms are levodopa dopamine agonists and Monoamine oxidases-B inhibitors.A multidisciplinary intensive rehabilitation treatment (MIRT) is able to improve different parameters in PD that are poorly responsive to the pharmacological therapy. In this study, we aim to understand whether the passive mobilization of the metatarsophalangeal joint of the hallux determines an increase in the joint range in this district, allowing to improve, at least, the gait in patients with PD. In this course, we will evaluate whether passive mobilization of this joint, lead to positive effects on the freezing of gait and on the festination.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria

PD patients stage 3 H&Y with FOG

Exclusion Criteria

we excluded patients with atypical parkinsonism, with other concomitant neurological conditions (with cerebrovascular etc.), with joint disorders, muscle disorders or with other orthopedic conditions.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Patients with passive joint mobilizationMIRTPatients diagnosed with PD according to the Gelb et al in Hoen\&Yahr stage 3, with Freezing of Gait and treated with a Multidisciplinary intensive rehabilitation treatment (MIRT), including the mobilization of the metatarsophalangeal joint of the hallux
Patients with passive joint mobilizationMobilization of the metatarsophalangeal joint of the halluxPatients diagnosed with PD according to the Gelb et al in Hoen\&Yahr stage 3, with Freezing of Gait and treated with a Multidisciplinary intensive rehabilitation treatment (MIRT), including the mobilization of the metatarsophalangeal joint of the hallux
No passive joint mobilizationMIRTPatients diagnosed with PD according to the Gelb et al in Hoen\&Yahr stage 3, with Freezing of Gait and treated with a Multidisciplinary intensive rehabilitation treatment (MIRT)
Primary Outcome Measures
NameTimeMethod
FOGQOne month

Freezing of Gait Questionnaire Value

Secondary Outcome Measures
NameTimeMethod
UPDRS IIIOne month

Unified Parkinson's disease Rating Scale

BBSOne month

Berg Balance Scale

HalluxOne month

Range of metatarsophalangeal joint value

Trial Locations

Locations (1)

Parkinson's Disease and Movement Disorders Rehabilitation Unit

🇮🇹

Gravedona, Como, Italy

© Copyright 2025. All Rights Reserved by MedPath